• Home
  • For Investors
  • Contact Us
  • More
    • Home
    • For Investors
    • Contact Us
  • Home
  • For Investors
  • Contact Us

For Investors

Linshom is an early stage, privately held start-up company with a mission to provide continuous respiratory monitoring for patients and health care providers to reduce morbidity & mortality associated with respiratory depression and compromise.


Subsequent to recent FDA clearance (Jan, 2020),  Linshom  is currently raising a series A round of funding that the company will use to  refine the existing sensor and integrate into a multi-parameter monitor.  In parallel Linshom will continue developing the evidence needed for rapid  clinical adoption and commercialization.

Linshom overview on GUST

Linshom overview on ProSeeder

Press Release, Linshom Receives SBIR Phase II Contract Award from the US Air Force (pdf)Download
Press Release, Linshom, European Patents 1/25/21 (pdf)Download
Press Release, Linshom, FDA Clearance 2/03/20 (pdf)Download
Second Quarter 20 Investor & Stakeholder Update (pdf)Download
First Quarter 20 Investor & Stakeholder Update (pdf)Download
Fourth Quarter 19 Investor & Stakeholder Update (pdf)Download

Contact for Investors

Richard Hughen - CEO

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Linshom Management LLC

RHughen@LinshomForLife.com (443) 994-1448

Copyright © 2019 Linshom Management LLC - All Rights Reserved.

  • Contact Us